Vancomycin-induced thrombocytopenia in a 60-year-old man: A case report

Journal of Medical Case Reports

Volumn 3, Issue , 2009, Pages

  Shah, Ravish A ^a   Musthaq, Adnan ^a   Khardori, Nancy ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; HEPARIN; IMMUNOGLOBULIN G ANTIBODY; METICILLIN; THROMBOCYTE ANTIBODY; TIGECYCLINE; VANCOMYCIN;

ADULT; ANAMNESIS; ANTIBIOTIC SENSITIVITY; ANTIBODY DETECTION; ARTICLE; CASE REPORT; CONGESTIVE HEART FAILURE; DIFFERENTIAL DIAGNOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; DYSLIPIDEMIA; ENTEROCOCCAL INFECTION; ENTEROCOCCUS; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HYPERTENSION; LAVAGE; MALE; PETECHIA; PRIORITY JOURNAL; ROTATOR CUFF RUPTURE; SERRATIA MARCESCENS; SHOULDER ARTHROSCOPY; SHOULDER PAIN; SHOULDER SURGERY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SURGICAL DRAINAGE; SWELLING; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT RESPONSE;

EID: 72249105559     PISSN: 17521947     EISSN: 17521947     Source Type: Journal    
DOI: 10.4076/1752-1947-3-7290     Document Type: Article

References (15)

1. Vancomycin-induced thrombocytopenia: a case proven with rechallenge. J Marraffa R Guharoy D Duggan F Rose S Nazeer, Pharmacotherap 2003 23 1195 1198 10.1592/phco.23.10.1195.32765 14524652
2. Alternatives to vancomycin in the treatment of MRSA infections. M Rahman, J Antimicrob Chemother 1998 41 325 328 10.1093/jac/41.3.325 9578158
3. Emergence of methicillin-resistant Staphylococcus aureus with intermediate glycopeptide resistance: clinical significance and treatment options. MJ Rybak RL Akins, Drug 2001 61 1 7 10.2165/00003495-200161010-00001 11217866
4. MRSA and VRE - therapeutic realities and possibilities. M Michel L Gutmann, Lancet 1997 349 1901 1906 10.1016/S0140-6736(96)11192-2 9217771
5. Vancomycin-induced immune thrombocytopenia. A Drygalski B Curtis D Bougie J McFarland S Ahl I Limbu K Baker R Aster, NEJM 2007 356 904 910 10.1056/NEJMoa065066 17329697
6. Historical yearly usage of vancomycin. HA Kirst, Antimicrob Agents Chemother 1998 42 5 1303 1304 9593175
7. The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study. J Ena RW Dick RN Jones, JAMA 1993 269 598 602 10.1001/jama.269.5.598 8240468
8. Vancomycin-associated thrombocytopenia: case report and review of the literature. JC Kuruppu TP Le CU Tuazon, Am J Hematol 1999 60 249 250 10.1002/(SICI)1096-8652(199903)60:3<249::AID-AJH20>3.0.CO;2-H 10072125
9. Vancomycin-dependent antibodies associated with thrombocytopenia and refractoriness to platelet transfusion in patients with leukemia. DJ Christie N van Buren SS Lennon JL Putnam, Blood 1990 75 518 523 2295006
10. Thrombocytopenia induced by vancomycin-dependent platelet antibody. P Mizon V Kiefel L Mannessier C Mueller-Eckhardt J Goudemand, Vox Sang 1997 73 49 51 10.1046/j.1423-0410.1997.7310049.x 9269071
11. Drug-induced immune cytopenias. RH Aster, Toxicology 2005 209 149 153 10.1016/j.tox.2004.12.031 15767027
12. Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors. MA Crowther DJ Cook MO Meade, et al. J Crit Care 2005 20 348 353 10.1016/j.jcrc.2005.09.008 16310606
13. Critical care clotting catastrophies. TG DeLoughery, Crit Care Clin 2005 21 531 562 10.1016/j.ccc.2005.05.003 15992672
14. Heparin-induced thrombocytopenia and thrombosis. A Davoren RH Aster, Am J Hematol 2006 81 36 44 10.1002/ajh.20490 16369980
15. Drug-induced immune-mediated thrombocytopenia - from purpura to thrombosis. T Warkentin, NEJM 2007 356 891 893 10.1056/NEJMp068309 17329695